A nurse is caring for a patient with acute lymphoblastic leukemia (ALL) who has just completed the first cycle of chemotherapy. Which nursing intervention should be the highest priority?

With severe thrombocytopenia (platelet count 15,000/mm³), the patient is at critical risk for spontaneous bleeding and hemorrhage, making bleeding precautions the highest priority intervention. Other options address less immediate concerns like oxygenation, hydration, or nutrition.

Core Nursing Explanation Key Concept Analysis: This question tests the ability to prioritize nursing interventions for a patient with acute lymphoblastic leukemia (ALL) who is experiencing the expected toxic effects of chemotherapy—myelosuppression. The key is to apply the ABC (Airway, Breathing, Circulation) priority framework and the concept of Key Point! Maslow's Hierarchy of Needs, where physiological safety from life-threatening complications takes precedence. The lab values reveal three critical problems: Neutropenia (WBC 1,200/mm³), Severe thrombocytopenia (Platelets 15,000/mm³), and Anemia (Hgb 7.2 g/dL). The symptom of petechiae is a direct sign of the low platelet count.

Answer Rationale: Option ② is correct because it directly addresses the most immediate, life-threatening risk. A platelet count of 15,000/mm³ indicates a high risk for spontaneous, potentially fatal internal bleeding (e.g., intracranial hemorrhage). Key Point! Bleeding precautions (e.g., using a soft-bristle toothbrush, avoiding IM injections, preventing falls) are non-invasive, preventative nursing actions that protect the patient from harm. Monitoring for signs of hemorrhage (e.g., changes in mental status, tachycardia, hypotension, melena) allows for early intervention. This aligns with the safety and physiological integrity needs, which are the highest priority.

Distractor Analysis:
Watch out for confusion! Option ① (Administer oxygen) might seem urgent due to the anemia (Hgb 7.2 g/dL), which can cause weakness and fatigue. However, the patient is not reported to have dyspnea, cyanosis, or low oxygen saturation. Oxygen therapy is not indicated based on the data provided and does not address the most critical threat.
Option ③ (Encourage fluids) is important for general patient care and to support renal function after chemotherapy, but dehydration is not an identified problem in this scenario. It is a lower priority than preventing a hemorrhage.
Option ④ (Provide high-protein meals) addresses the long-term need for healing and combating the catabolic effects of cancer and treatment. While nutrition is important, it is not the priority when the patient is at immediate risk for a life-threatening bleed.

Related Concepts: This scenario integrates oncology nursing, management of chemotherapy complications, and interpretation of critical lab values. The nurse must also be vigilant for signs of infection due to neutropenia (WBC 1,200/mm³), but the presence of petechiae specifically points to the bleeding risk as the most pressing issue at this moment.

Concept Summary
Problem: Post-chemotherapy myelosuppression in ALL.
Key Data: Platelets 15,000/mm³ (Critical), Petechiae (Clinical sign).
Priority Need: Safety from hemorrhage.
Core Intervention: Implement bleeding precautions and vigilant monitoring.

Side-by-Side Comparison!

Complication	Key Lab Value	Priority Nursing Intervention	Rationale
Thrombocytopenia (Bleeding Risk)	Platelets < 20,000/mm³	Implement bleeding precautions; monitor for hemorrhage.	Prevent life-threatening spontaneous bleeding (e.g., intracranial, GI).
Neutropenia (Infection Risk)	Absolute Neutrophil Count (ANC) < 500/mm³	Implement neutropenic precautions (e.g., private room, strict hand hygiene).	Prevent sepsis, which is also life-threatening but may have a slightly slower onset than massive hemorrhage.
Anemia (Fatigue/O2 Carry)	Hgb < 8 g/dL	Monitor for dyspnea, fatigue; plan energy conservation; prepare for possible transfusion.	Addresses tissue oxygenation but is often less immediately life-threatening than active bleeding or sepsis.

Anatomy, Physiology & Pharmacology Points
Pathophysiology: Chemotherapy targets rapidly dividing cells, including cancer cells in the bone marrow. This destroys the hematopoietic stem cells, leading to a drop in all blood cell lines (pancytopenia): red blood cells (anemia), white blood cells (neutropenia), and platelets (thrombocytopenia).
Pharmacology: Chemotherapy drugs for ALL (e.g., vincristine, prednisone, asparaginase) are highly myelosuppressive. Nurses must know nadir times (when blood counts are lowest, typically 7-14 days post-treatment).

Memory Tips
Priority Acronym: "Bleeding before Breathing before Breakfast." When platelets are critically low (

Nursing Clinical Practice Guide Clinical Scenario: You are the nurse on an oncology unit. Your patient, Mr. Johnson, 45, with ALL, is day 10 post-chemotherapy. He says he feels more tired than usual, and you note new, pinpoint red spots (petechiae) on his forearms and shins. You immediately check his latest CBC (Complete Blood Count).

Nursing Intervention Strategy: 1. Assessment: Perform a focused assessment. Check vital signs (tachycardia, hypotension could indicate bleeding). Perform a thorough skin assessment for more petechiae, ecchymosis, or active bleeding from gums or IV sites. Assess neurological status (for intracranial bleed). Ask about headache, vision changes, abdominal pain, or blood in urine/stool. 2. Nursing Diagnosis: Risk for Bleeding related to severe thrombocytopenia. 3. Planning & Implementation:

• Bleeding Precautions (Environment & Care): Place a "Bleeding Precautions" sign. Use electric razor only. Provide soft-bristle toothbrush. Avoid intramuscular injections and rectal temps/suppositories. Use gentle suctioning if needed. Pad side rails.
• Activity: Encourage quiet activities. Assist with ambulation to prevent falls.
• Monitoring: Check platelet count daily. Monitor stool, urine, emesis for occult blood. Assess skin and mucous membranes q4h.
• Collaboration: Notify the provider of the critical platelet count. Prepare for a possible platelet transfusion per order.

4. Patient Education: Teach the patient and family to recognize signs of bleeding (e.g., bruising, blood in spit, black stools) and to report them immediately. Instruct to avoid NSAIDs (e.g., ibuprofen, aspirin).

Patient Safety and Precautions: - Contraindications: Do not administer antiplatelet or anticoagulant medications. - Medication Caution: Hold any medication that could increase bleeding risk until reviewed with provider. - Key Monitoring: Any change in level of consciousness is a RED FLAG for possible intracranial hemorrhage and requires immediate emergency response.

Nursing Procedure & Medication Flow If a Platelet Transfusion is Ordered: 1. Verify order and consent. 2. Obtain platelets from blood bank—they are stored at room temperature and agitated, so transfuse immediately upon receipt. 3. Use a standard blood transfusion set (170-200 micron filter). Do not use medications or other fluids in the same line. 4. Transfuse rapidly (as tolerated by the patient), usually over 15-30 minutes per unit, as platelets have a short shelf life. 5. Monitor closely for transfusion reactions (fever, chills, urticaria, dyspnea) during the first 15 minutes. 6. Reassess platelet count per protocol post-transfusion.

A Word from Your Senior Nurse "In the whirlwind of oncology nursing, your eyes and assessment skills are your best tools. A few petechiae might seem minor, but paired with that critically low platelet count, they're a flashing warning sign. Prioritizing isn't just about the textbook list; it's about seeing which silent threat is most likely to harm your patient *right now*. Mastering this kind of clinical judgment—connecting the dots between labs, symptoms, and risk—is what will make you an exceptional nurse, both on the NCLEX and at the bedside."